ILIAS

Manufacturing

Pure-Exo®

Platform technology for high-purity
exosome manufacturing on
a commercial scale

Exosome Manufacturing for Therapeutic Application

The development of exosomes for therapeutic applications depends
on reproducible and analytical technologies
for the production and purification of clinical-grade exosomes which
can be applied on a commercial scale.

info-img
  • Master Cell Bank (MCB)

    The success of the exosome manufacturing process starts with the development of a stable cell line for exosome
    production. ILIAS establishes Master cell banks (MCB) and characterizes them thoroughly with high standards for
    cGMP requirements.

  • Cell Culture

    ILIAS has successfully established scalable manufacturing processes using ILIAS’s bioreactor technology for suspension cell
    culture to which ILIAS’ EXPLOR® technology can be applied.

  • Filtration and Chromatography

    Exosomes are isolated sequentially by ultrafiltration and chromatography to produce highly purified exosomes with
    high yields.

  • Formulation and Filling

    Our exosome-based pharmaceuticals are properly formulated and packaged in GMP facilities to sustain stability.